In the News
Two-dose recombinant shingles vaccine effective, even in patients who got live version
Two doses of the recombinant vaccine had a relative effectiveness of 67.9% versus one dose, and the second dose was similarly effective whether administered within the CDC-recommended interval of two to six months after the first or within an extended window.
2024-2025 COVID-19 vaccine associated with reduced hospitalizations, deaths
The COVID-19 vaccine had an effectiveness of 29.3% against related ED visits, 39.2% against hospitalization, and 64.0% against COVID-19-associated death, according to a comparison of U.S. veterans who got both COVID-19 and flu vaccines and those who got only flu shots.
MKSAP Quiz: 1-year history of worsening dyspnea
A 46-year-old woman is evaluated for a 1-year history of worsening dyspnea with exertion and a 4-month history of iron deficiency anemia, which has not responded to iron supplementation. Following a physical exam, lab studies, and upper endoscopy and colonoscopy, what is the most appropriate next step in management?
Patients with hyperglycemia during ICU stay have higher risk of postdischarge diabetes
Critical illness-associated hyperglycemia is associated with a 4.1% risk of new-onset diabetes within five years of discharge, compared to 1.8% in patients who didn't develop high blood glucose levels in the ICU, a Swedish study found.
Virtual workshop to offer physicians help on science communication
The Coalition for Trust in Health ##amp; Science is hosting a free, three-part virtual workshop series on Oct. 23, Nov. 6, and Nov. 20.
ACP announces 2025-2026 recipients of Mastership, national awards
The list of winners is available on ACP Online.